ARCHIVES

News Analysis: Generic Drug Industry’s Efforts to Eliminate Shortages Raises Antitrust Law Questions

This article is from The Cancer Letter archive.

Vol. 38 No. 17 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Final Count On Funded CCOPs Probably Delayed for Months; Many To Continue Without NCI Money

April 24, 1987

AACR considering new office in D.C.

July 18, 2003

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

February 25, 2000

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

August 27, 2010

Congress Investigates “Lecture Awards” To Former NCI Director Richard Klausner.

July 4, 2003

NCI To Ask HCFA to Launch Pilot Clinical Trials Program

March 22, 1996